Fortress Biotech Inc (FBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $62.70M
Last updated: Nov 17, 2026 at 11:04 AM ET
Fortress Biotech Inc (FBIO) Competitors
The companies most similar to Fortress Biotech are iBio, Inc. Common Stock (IBIO), Gain Therapeutics (GANX) and XBiotech (XBIT). By market cap, Fortress Biotech ranks 5th of the 13 companies on this page; OUTLOOK THERAPEUTICS INC (OTLK) is the largest at $100.54M.
Peer Comparison
FBIO's ROIC of 57.0% is above the peer median of -152.2%, and its revenue growth of 8.7% is above the median of -14.8%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Fortress Biotech (FBIO) | $62.70M | 0.7x | 0.8x | 143.1% | 57.0% | 8.7% | 0.00% |
| iBio, Inc. Common Stock (IBIO) | $51.55M | N/A | 735.4x | 0.0% | N/A | 975.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Nutriband Inc (NTRB) | $74.15M | N/A | 43.7x | 0.0% | -101.3% | -29.7% | 0.00% |
| Biomea Fusion Inc (BMEA) | $42.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tonix Pharmaceuticals Holding Corp (TNXP) | $58.49M | N/A | 1.2x | 0.0% | N/A | 423.8% | 0.00% |
| OUTLOOK THERAPEUTICS INC (OTLK) | $100.54M | N/A | N/A | 0.0% | -776.9% | -99.4% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Milestone Pharmaceuticals Inc (MIST) | $64.74M | N/A | 8.6x | 0.0% | -133.9% | -100.0% | 0.00% |
| Peer median | $55.03M | 4.1x | 11.1x | 0.0% | -152.2% | -14.8% | 0.00% |
Similar Companies
These are the 12 companies most similar to Fortress Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| iBio, Inc. Common Stock (IBIO) | iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. | IBIO competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| Nutriband Inc (NTRB) | Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida. | NTRB competitors |
| Biomea Fusion Inc (BMEA) | Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat... | BMEA competitors |
| Tonix Pharmaceuticals Holding Corp (TNXP) | Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey. | TNXP competitors |
| OUTLOOK THERAPEUTICS INC (OTLK) | Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic... | OTLK competitors |
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| Milestone Pharmaceuticals Inc (MIST) | Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. | MIST competitors |
Frequently Asked Questions About FBIO
Who are Fortress Biotech's main competitors?
The companies most similar to Fortress Biotech include iBio, Inc. Common Stock (IBIO), Gain Therapeutics (GANX), XBiotech (XBIT), Connect Biopharma Holdings (CNTB) and Actinium Pharmaceuticals (ATNM), listed from the closest match.
Who is Fortress Biotech's biggest competitor?
OUTLOOK THERAPEUTICS INC (OTLK) is the largest of the similar companies at $100.54M; iBio, Inc. Common Stock (IBIO) is the closest match by business profile, size, sector and industry.
How does FBIO stock compare with its competitors?
FBIO's P/E is 0.7x against a peer median of 4.1x; its P/S is 0.8x against a peer median of 11.1x; its net margin is 143.1% against a peer median of 0.0%.
Which of Fortress Biotech's competitors pays a higher dividend?
Fortress Biotech pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Fortress Biotech bigger than its competitors?
No. Fortress Biotech is 5th by market cap among the 13 companies on this page; the largest is OUTLOOK THERAPEUTICS INC (OTLK) at $100.54M.
FBIO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors